The aim of the present study was to elucidate the role of GLT-1 in ceftriaxone-mediated improvement on cognitive deficits and associated changes in xCT (catalytic subunit of system xc–) expression and activity using GLT-1 knockdown APP/PS1 mice. The gene discussed is SLC7A11; the disease is Cognitive impairment.